Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 40, 2014, Pages E4244-E4253

  KöNiger, Christian ^a,b   Wingert, Ida ^a   Marsmann, Moritz ^a   Rösler, Christine ^a   Beck, Jörgen ^a   Nassal, Michael ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULAR DNA; DNA TOPOISOMERASE; GLYCINE DEHYDROGENASE (DECARBOXYLATING); MESSENGER RNA; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; SHORT HAIRPIN RNA; TDP1 PROTEIN; TDP2 PROTEIN; UNCLASSIFIED DRUG; AVIAN PROTEIN; NUCLEAR PROTEIN; PHOSPHODIESTERASE; TDP1 PROTEIN, HUMAN; TDP2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; VIRUS DNA;

CONFERENCE PAPER; DNA ADDUCT; DNA REPAIR; DNA STRUCTURE; ELECTROPHORESIS; ENZYME ACTIVITY; HEPATITIS B VIRUS; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; ANIMAL; CHEMISTRY; CHICKEN; CONFORMATION; DUCK HEPATITIS B VIRUS; GENETICS; IMMUNOBLOTTING; METABOLISM; NUCLEOTIDE SEQUENCE; RNA INTERFERENCE; TUMOR CELL LINE; VIRUS REPLICATION;

ANIMALS; AVIAN PROTEINS; BASE SEQUENCE; CELL LINE, TUMOR; CHICKENS; DNA REPAIR; DNA, CIRCULAR; DNA, VIRAL; HEP G2 CELLS; HEPATITIS B VIRUS; HEPATITIS B VIRUS, DUCK; HUMANS; IMMUNOBLOTTING; NUCLEAR PROTEINS; NUCLEIC ACID CONFORMATION; PHOSPHORIC DIESTER HYDROLASES; RNA INTERFERENCE; TRANSCRIPTION FACTORS; VIRUS REPLICATION;

EID: 84920764736     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1409986111     Document Type: Article

References (65)

1. Ott JJ, Stevens GA, Groeger J, Wiersma ST (2012) Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30(12):2212-2219.
2. Ganem D, Prince AM (2004) Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350(11):1118-1129.
3. Zoulim F, Locarnini S (2009) Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology 137(5):1593-1608 e1591-1592.
4. Scaglione SJ, Lok AS (2012) Effectiveness of hepatitis B treatment in clinical practice. Gastroenterology 142(6):1360-1368 e1361.
5. Beck J, Nassal M (2007) Hepatitis B virus replication. World J Gastroenterol 13(1): 48-64.
6. Nassal M (2008) Hepatitis B viruses: Reverse transcription a different way. Virus Res 134(1-2):235-249.
7. Hu J, Anselmo D (2000) In vitro reconstitution of a functional duck hepatitis B virus reverse transcriptase: Posttranslational activation by Hsp90. J Virol 74(24):11447-11455.
8. Beck J, Nassal M (2001) Reconstitution of a functional duck hepatitis B virus replication initiation complex from separate reverse transcriptase domains expressed in Escherichia coli. J Virol 75(16):7410-7419.
9. Beck J, Nassal M (2003) Efficient Hsp90-independent in vitro activation by Hsc70 and Hsp40 of duck hepatitis B virus reverse transcriptase, an assumed Hsp90 client protein. J Biol Chem 278(38):36128-36138.
10. Stahl M, Retzlaff M, Nassal M, Beck J (2007) Chaperone activation of the hepadnaviral reverse transcriptase for template RNA binding is established by the Hsp70 and stimulated by the Hsp90 system. Nucleic Acids Res 35(18):6124-6136.
11. Tuttleman JS, Pourcel C, Summers J (1986) Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47(3):451-460.
12. Chen SH, Chan NL, Hsieh TS (2013) New mechanistic and functional insights into DNA topoisomerases. Annu Rev Biochem 82:139-170.
13. Pommier Y (2013) Drugging topoisomerases: Lessons and challenges. ACS Chem Biol 8(1):82-95.
14. Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K, Linn S (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73: 39-85.
15. Deriano L, Roth DB (2013) Modernizing the nonhomologous end-joining repertoire: Alternative and classical NHEJ share the stage. Annu Rev Genet 47:433-455.
16. Huang SN, Pommier Y, Marchand C (2011) Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors. Expert Opin Ther Pat 21(9):1285-1292.
17. Yang SW, et al. (1996) A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases. Proc Natl Acad Sci USA 93(21): 11534-11539.
18. Nitiss KC, Malik M, He X, White SW, Nitiss JL (2006) Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage. Proc Natl Acad Sci USA 103(24):8953-8958.
19. Murai J, et al. (2012) Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells. J Biol Chem 287(16):12848-12857.
20. Zeng Z, et al. (2012) TDP2 promotes repair of topoisomerase I-mediated DNA damage in the absence of TDP1. Nucleic Acids Res 40(17):8371-8380.
21. Pommier Y, et al. (2006) Repair of topoisomerase I-mediated DNA damage. Prog Nucleic Acid Res Mol Biol 81:179-229.
22. Maede Y, et al. (2014) Differential and common DNA repair pathways for topoisomerase I-And II-Targeted drugs in a genetic DT40 repair cell screen panel. Mol Cancer Ther 13(1):214-220.
23. Hartsuiker E, Neale MJ, Carr AM (2009) Distinct requirements for the Rad32(Mre11) nuclease and Ctp1(CtIP) in the removal of covalently bound topoisomerase I and II from DNA. Mol Cell 33(1):117-123.
24. Nakamura K, et al. (2010) Collaborative action of Brca1 and CtIP in elimination of covalent modifications from double-strand breaks to facilitate subsequent break repair. PLoS Genet 6(1):e1000828.
25. Li C, Sun SY, Khuri FR, Li R (2011) Pleiotropic functions of EAPII/TTRAP/TDP2: Cancer development, chemoresistance and beyond. Cell Cycle 10(19):3274-3283.
26. Cortes Ledesma F, El Khamisy SF, Zuma MC, Osborn K, Caldecott KW (2009) A human 5?-Tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage. Nature 461(7264):674-678.
27. Caldecott KW (2012) Tyrosyl DNA phosphodiesterase 2, an enzyme fit for purpose. Nat Struct Mol Biol 19(12):1212-1213.
28. Schellenberg MJ, et al. (2012) Mechanism of repair of 5?-Topoisomerase II-DNA adducts by mammalian tyrosyl-DNA phosphodiesterase 2. Nat Struct Mol Biol 19(12): 1363-1371.
29. Shi K, et al. (2012) Structural basis for recognition of 5?-phosphotyrosine adducts by Tdp2. Nat Struct Mol Biol 19(12):1372-1377.
30. Zeng Z, Cortés-Ledesma F, El Khamisy SF, Caldecott KW (2011) TDP2/TTRAP is the major 5?-Tyrosyl DNA phosphodiesterase activity in vertebrate cells and is critical for cellular resistance to topoisomerase II-induced DNA damage. J Biol Chem 286(1): 403-409.
31. Virgen-Slane R, et al. (2012) An RNA virus hijacks an incognito function of a DNA repair enzyme. Proc Natl Acad Sci USA 109(36):14634-14639.
32. Weitzman MD, Lilley CE, Chaurushiya MS (2010) Genomes in conflict: Maintaining genome integrity during virus infection. Annu Rev Microbiol 64:61-81.
33. Rideout MC, Raymond AC, Burgin AB, Jr (2004) Design and synthesis of fluorescent substrates for human tyrosyl-DNA phosphodiesterase I. Nucleic Acids Res 32(15): 4657-4664.
34. Gao R, Huang SY, Marchand C, Pommier Y (2012) Biochemical characterization of human tyrosyl-DNA phosphodiesterase 2 (TDP2/TTRAP): A Mg(2+)/Mn(2+)-dependent phosphodiesterase specific for the repair of topoisomerase cleavage complexes. J Biol Chem 287(36):30842-30852.
35. Jones SA, Boregowda R, Spratt TE, Hu J (2012) In vitro epsilon RNA-dependent protein priming activity of human hepatitis B virus polymerase. J Virol 86(9):5134-5150.
36. Radziwill G, Zentgraf H, Schaller H, Bosch V (1988) The duck hepatitis B virus DNA polymerase is tightly associated with the viral core structure and unable to switch to an exogenous template. Virology 163(1):123-132.
37. Guo JT, et al. (2003) Conditional replication of duck hepatitis B virus in hepatoma cells. J Virol 77(3):1885-1893.
38. Gerlich WH, Robinson WS (1980) Hepatitis B virus contains protein attached to the 5? terminus of its complete DNA strand. Cell 21(3):801-809.
39. Köck J, et al. (2010) Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner. PLoS Pathog 6(9): e1001082.
40. Sun D, Nassal M (2006) Stable HepG2-And Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus. J Hepatol 45(5):636-645.
41. Reaiche-Miller GY, et al. (2013) Duck hepatitis B virus covalently closed circular DNA appears to survive hepatocyte mitosis in the growing liver. Virology 446(1-2):357-364.
42. Thomson G, et al. (2013) Generation of assays and antibodies to facilitate the study of human 5?-Tyrosyl DNA phosphodiesterase. Anal Biochem 436(2):145-150.
43. Li C, et al. (2011) Oncogenic role of EAPII in lung cancer development and its activation of the MAPK-ERK pathway. Oncogene 30(35):3802-3812.
44. Ichihara M, et al. (2007) Thermodynamic instability of siRNA duplex is a prerequisite for dependable prediction of siRNA activities. Nucleic Acids Res 35(18):e123.
45. Sun D, Rösler C, Kidd-Ljunggren K, Nassal M (2010) Quantitative assessment of the antiviral potencies of 21 shRNA vectors targeting conserved, including structured, hepatitis B virus sites. J Hepatol 52(6):817-826.
46. Zucchelli S, et al. (2009) Aggresome-forming TTRAP mediates pro-Apoptotic properties of Parkinson's disease-Associated DJ-1 missense mutations. Cell Death Differ 16(3):428-438.
47. Nikolova N, Tenekedjiev K, Kolev K (2008) Uses and misuses of progress curve analysis in enzyme kinetics. Cent Eur J Biol 3(4):345-350.
48. Königer C (2014) Impact of cellular DNA repair factors on formation of the covalently closed circular (ccc) DNA of hepatitis B viruses. PhD thesis (University of Freiburg, Freiburg, Germany).
49. Das BB, et al. (2014) PARP1-TDP1 coupling for the repair of topoisomerase I-induced DNA damage. Nucleic Acids Res 42(7):4435-4449.
50. Adhikari S, et al. (2011) Development of a novel assay for human tyrosyl DNA phosphodiesterase 2. Anal Biochem 416(1):112-116.
51. Vörös J, et al. (2014) Large-scale production and structural and biophysical characterizations of the human hepatitis B virus polymerase. J Virol 88(5):2584-2599.
52. Nassal M, Rieger A (1996) A bulged region of the hepatitis B virus RNA encapsidation signal contains the replication origin for discontinuous first-strand DNA synthesis. J Virol 70(5):2764-2773.
53. Jones SA, Hu J (2013) Protein-primed terminal transferase activity of hepatitis B virus polymerase. J Virol 87(5):2563-2576.
54. Interthal H, Champoux JJ (2011) Effects of DNA and protein size on substrate cleavage by human tyrosyl-DNA phosphodiesterase 1. Biochem J 436(3):559-566.
55. Kenney JM, von Bonsdorff CH, Nassal M, Fuller SD (1995) Evolutionary conservation in the hepatitis B virus core structure: Comparison of human and duck cores. Structure 3(10):1009-1019.
56. Nassal M, et al. (2007) A structural model for duck hepatitis B virus core protein derived by extensive mutagenesis. J Virol 81(23):13218-13229.
57. Birnbaum F, Nassal M (1990) Hepatitis B virus nucleocapsid assembly: Primary structure requirements in the core protein. J Virol 64(7):3319-3330.
58. Nitiss JL, Nitiss KC (2013) Tdp2: A means to fixing the ends. PLoS Genet 9(3):e1003370.
59. Tsutakawa SE, Lafrance-Vanasse J, Tainer JA (2014) The cutting edges in DNA repair, licensing, and fidelity: DNA and RNA repair nucleases sculpt DNA to measure twice, cut once. DNA Repair (Amst) 19:95-107.
60. d'Adda di Fagagna F (2014) A direct role for small non-coding RNAs in DNA damage response. Trends Cell Biol 24(3):171-178.
61. Kann M, Schmitz A, Rabe B (2007) Intracellular transport of hepatitis B virus. World J Gastroenterol 13(1):39-47.
62. Chevaliez S, Hézode C, Bahrami S, Grare M, Pawlotsky JM (2013) Long-Term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely. J Hepatol 58(4):676-683.
63. Levrero M, et al. (2009) Control of cccDNA function in hepatitis B virus infection. J Hepatol 51(3):581-592.
64. Zeisel MB, Lupberger J, Fofana I, Baumert TF (2013) Host-Targeting agents for prevention and treatment of chronic hepatitis C-perspectives and challenges. J Hepatol 58(2):375-384.
65. Lucifora J, et al. (2014) Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science 343(6176):1221-1228.